InsidersTradesSigma
Follow the 셀루메드 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 셀루메드 has logged 1 public disclosures. Market capitalisation: €83.9bn. The latest transaction was filed on 19 March 2026 (Sale). Among the most active insiders: 인스코비. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
셀루메드 opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. La empresa se centra en el desarrollo de soluciones innovadoras para el campo médico.